Inventaire - your friends and communities are your best library

Tracking cancer drugs in living cells by thermal profiling of the proteome

author

Susan Klaeger

Rozbeh Jafari

Gerard Drewes

Bernhard Kuster

1967 -

Marcus Bantscheff

Dirk Eberhard

Mikhail M Savitski

Maria Fälth Savitski

Holger Franken

Thilo Werner

published in: Science

date of publication: 2014-10-02

language: English

Cites articles 35

Date

Title

Authors

2014-05-29

Mass-spectrometry-based draft of the human proteome

Mathias Wilhelm, Emanuel Ziegler, Siegfried Gessulat, Toby Mathieson, Bernhard Kuster, Karsten Schnatbaum, Ulf Reimer, Marcus Bantscheff, Mikhail M Savitski, Judith Schlegl, Simone Lemeer
2014-02-02

Minimal, encapsulated proteomic-sample processing applied to copy-number estimation in eukaryotic cells
2014-03-11

Ion coalescence of neutron encoded TMT 10-plex reporter ions

Toby Mathieson
2014-02-08

Overcoming the resistance to crizotinib in patients with non-small cell lung cancer harboring EML4/ALK translocation
2013-07-01

Monitoring drug target engagement in cells and tissues using the cellular thermal shift assay

Rozbeh Jafari, Andreas Larsson
2013-04-01

Determining target engagement in living systems

Benjamin Cravatt
2013-01-07

Affinity profiling of the cellular kinome for the nucleotide cofactors ATP, ADP, and GTP.

Isabelle Becher, Gerard Drewes, Carsten Hopf, Marcus Bantscheff, Mikhail M Savitski, Maria Fälth Savitski
2013-06-25

Characterization of the novel broad-spectrum kinase inhibitor CTx-0294885 as an affinity reagent for mass spectrometry-based kinome profiling

Thomas S. Peat, Roger J. Daly
2013-04-01

Erythroid heme biosynthesis and its disorders
2013-04-01

Vemurafenib: an unusual UVA-induced photosensitivity.

Caroline Schmitt, Brigitte Dréno
2013-07-02

Measuring and managing ratio compression for accurate iTRAQ/TMT quantification.

Isabelle Becher, Bernhard Kuster, Toby Mathieson, Marcus Bantscheff, Gavain M A Sweetman, Mikhail M Savitski, Carola Doce, Fiona Pachl
2012-01-01

Mass spectrometry-based proteomics and network biology

Ruedi Aebersold
2012-09-16

Direct identification of ligand-receptor interactions on living cells and tissues

Andreas Plückthun, Ruedi Aebersold, Erick Moran Carreira
2012-09-30

Systems-pharmacology dissection of a drug synergy in imatinib-resistant CML

Giulio Superti-Furga, Florian Grebien, Florian P Breitwieser, Martin Bilban, Jacques Colinge, Peter Valent, Forest M. White, Keiryn L Bennett, Manuela Gridling, Uwe Rix
2012-04-01

Dynamic reprogramming of the kinome in response to targeted MEK inhibition in triple-negative breast cancer

Norman Sharpless, Charles M. Perou, Katherine A. Hoadley, David B Darr, Pei Fen Kuan, Jerry E Usary, Martin C Whittle
2012-08-08

High-resolution enabled TMT 8-plexing.

Isabelle Becher
2012-02-01

Structure and allostery of the PKA RIIβ tetrameric holoenzyme

Alexandr P Kornev
2011-01-01

Quantitative, high-resolution proteomics for data-driven systems biology

Jürgen Cox, Matthias Mann
2011-03

Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexes

Gerard Drewes, Gitte Neubauer, Anne-Marie Michon, Paola Grandi, Toby Mathieson, Yann Abraham, Isabelle Becher, Giovanna Bergamini, Carsten Hopf, Marcus Bantscheff, Dirk Eberhard, Markus Boesche, Valérie Reader, Gavain M A Sweetman, Ulrich Kruse, Nigel G Ramsden, Mikhail M Savitski, Antje Dittmann, Judith Schlegl, Birgit Dümpelfeld, Carola Huthmacher, Daniel Poeckel
2010-09-16

A novel p53 phosphorylation site within the MDM2 ubiquitination signal: II. a model in which phosphorylation at SER269 induces a mutant conformation to p53

Arumugam Madhumalar, Malcolm Walkinshaw, Elizabeth Blackburn
2010-02-28

Protein folding stability and dynamics imaged in a living cell

Simon Ebbinghaus, Martin Gruebele
2010-09-30

Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma

Joseph Schlessinger, Antoni Ribas, Igor Puzanov, Grant McArthur, Katherine L Nathanson, Rafe Shellooe, Gideon Bollag, Gaston Habets, Keith Flaherty, Chao Zhang
2010-10-14

Chemoproteomics-based kinome profiling and target deconvolution of clinical multi-kinase inhibitors in primary chronic lymphocytic leukemia cells

Christian P. Pallasch, Gerard Drewes
2010-01-25

Targeted data acquisition for improved reproducibility and robustness of proteomic mass spectrometry assays

Toby Mathieson
2009-02-03

GOrilla: a tool for discovery and visualization of enriched GO terms in ranked gene lists

Zohar Yakhini
2008-01-08

Comparison of imatinib, dasatinib, nilotinib and INNO-406 in imatinib-resistant cell lines
2008-12

MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification
2007-08-26

Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors

Gitte Neubauer, Toby Mathieson, Yann Abraham, Gerard Drewes, Carsten Hopf, Bernhard Kuster, Marcus Bantscheff, Dirk Eberhard, Sonja Bastuck, Markus Boesche, Jessica Perrin, Manfred Raida, Valérie Reader, Gavain M A Sweetman, Tewis Bouwmeester, Ulrich Kruse, Nigel G Ramsden, Jens Rick
2006-10-11

Chemical screening methods to identify ligands that promote protein stability, protein crystallization, and structure determination

Aled Edwards, Oleg Fedorov, Cheryl Arrowsmith, Gregory A Wasney
2006-06-01

BCR-ABL activity and its response to drugs can be determined in CD34+ CML stem cells by CrkL phosphorylation status using flow cytometry

Mhairi Copland, Tessa Holyoake
2004-07-16

Overriding imatinib resistance with a novel ABL kinase inhibitor
2002-04-01

Kinetics of protein aggregation. Quantitative estimation of the chaperone-like activity in test-systems based on suppression of protein aggregation

Article - wd:Q34441561

Welcome to Inventaire

the library of your friends and communities

learn more